Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Deferred Taxes (2016 - 2020)

Historic Deferred Taxes for Immucell (ICCC) over the last 11 years, with Q4 2020 value amounting to $1.0.

  • Immucell's Deferred Taxes rose 10001.41% to $1.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$14631.0, marking a year-over-year decrease of 15927.32%. This contributed to the annual value of -$14631.0 for FY2020, which is 15927.32% down from last year.
  • Immucell's Deferred Taxes amounted to $1.0 in Q4 2020, which was up 10001.41% from -$14632.0 recorded in Q1 2020.
  • Immucell's Deferred Taxes' 5-year high stood at $498822.0 during Q2 2018, with a 5-year trough of -$293921.0 in Q4 2017.
  • In the last 5 years, Immucell's Deferred Taxes had a median value of -$2089.0 in 2016 and averaged $23547.1.
  • As far as peak fluctuations go, Immucell's Deferred Taxes crashed by 166736.06% in 2017, and later skyrocketed by 77537.98% in 2018.
  • Immucell's Deferred Taxes (Quarter) stood at $29378.0 in 2016, then crashed by 1100.48% to -$293921.0 in 2017, then soared by 104.95% to $14545.0 in 2018, then plummeted by 148.9% to -$7112.0 in 2019, then surged by 100.01% to $1.0 in 2020.
  • Its last three reported values are $1.0 in Q4 2020, -$14632.0 for Q1 2020, and -$7112.0 during Q4 2019.